Neuroimaging in the clinical diagnosis of dementia: Observations from a memory disorders clinic

Journal of the American Geriatrics Society

Volumn 58, Issue 8, 2010, Pages 1453-1458

  Borghesani, Paul R ^a   Demers, Shaune M ^a   Manchanda, Vivek ^a   Pruthi, Sumit ^b   Lewis, David H ^a   Borson, Soo ^a,c  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cognitive disorders; dementia; differential diagnosis; MRI; neuroimaging; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BRAIN; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; CYSTEINE; DEMENTIA; HUMANS; LEWY BODIES; MAGNETIC RESONANCE IMAGING; OXIMES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955265524     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02975.x     Document Type: Article

References (38)

1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998 88 : 1337 1342.
2. Knopman DS, DeKosky ST, Cummings JL et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 56 : 1143 1153.
3. Waldemar G, Dubois B, Emre M et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007 14 : e1 e26.
4. Swarztrauber K, Vickrey BG. Do neurologists and primary care physicians agree on the extent of specialty involvement of patients referred to neurologists? J Gen Intern Med 2004 19 : 654 661.
5. Hinton L, Franz CE, Reddy G et al. Practice constraints, behavioral problems, and dementia care: Primary care physicians' perspectives. J Gen Intern Med 2007 22 : 1487 1492.
6. Pimlott NJ, Persaud M, Drummond N et al. Family physicians and dementia in Canada: Part 1. Clinical practice guidelines: Awareness, attitudes, and opinions. Can Fam Physician 2009 55 : 506 507 e501-505.
7. Pimlott SL, Ebmeier KP. SPECT imaging in dementia. Br J Radiol 2007 80 : S153 S159.
8. Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol 2007 80 : S160 S167.
9. Borrie M. Functional neuroimaging in the diagnosis of dementia. Alzheimers Dement 2007 3 : 336 340.
10. Foster NL, Heidebrink JL, Clark CM et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 2007 130 : 2616 2635.
11. Silverman DH. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: Comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004 45 : 594 607.
12. Mueller SG, Weiner MW, Thal LJ et al. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005 1 : 55 66.
13. Langbaum JB, Chen K, Lee W et al. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 2009 45 : 1107 1116.
14. Herholz K, Schopphoff H, Schmidt M et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med 2002 43 : 21 26.
15. Pupi A, Nobili FM. PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease - against. Eur J Nucl Med Mol Imag 2005 32 : 1466 1472.
16. Burdette JH, Minoshima S, Vander Borght T et al. Alzheimer disease: Improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996 198 : 837 843.
17. Uchida Y, Minoshima S, Okada S et al. Diagnosis of dementia using perfusion SPECT imaging at the patient's initial visit to a cognitive disorder clinic. Clin Nucl Med 2006 31 : 764 773.
18. Stockbridge HL, Lewis D, Eisenberg B et al. Brain SPECT: A controlled, blinded assessment of intra-reader and inter-reader agreement. Nucl Med Commun 2002 23 : 537 544.
19. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983 40 : 812.
20. Borson S, Scanlan J, Brush M et al. The Mini-Cog: A cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000 15 : 1021 1027.
21. Borson S, Scanlan JM, Watanabe J et al. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry 2006 21 : 349 355.
22. Cummings JL, Mega M, Gray K et al. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994 44 : 2308 2314.
23. Pfeffer RI, Kurosaki TT, Harrah CH Jr. et al. Measurement of functional activities in older adults in the community. J Gerontol 1982 37 : 323 329.
24. Kapeller P, Schmidt R, Enzinger C et al. CT and MRI rating of white matter changes. J Neural Transm Suppl 2002, 41 45. (Pubitemid 37046650)
25. Knopman DS. Cerebrovascular disease and dementia. Br J Radiol 2007 80 Spec No 2 : S121 S127.
26. Juni JE, Waxman AD, Devous MD Sr. et al. Procedure guideline for brain perfusion SPECT using technetium-99m radiopharmaceuticals. Society of Nuclear Medicine. J Nucl Med 1998 39 : 923 926.
27. Minoshima S, Frey KA, Koeppe RA et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995 36 : 1238 1248.
28. Coimbra A, Williams DS, Hostetler ED. The role of MRI and PET/SPECT in Alzheimer's disease. Curr Top Med Chem 2006 6 : 629 647.
29. Condefer KA, Haworth J, Wilcock GK. Clinical utility of computed tomography in the assessment of dementia: A memory clinic study. Int J Geriatr Psychiatry 2004 19 : 414 421.
30. Geroldi C, Canu E, Bruni AC et al. The added value of neuropsychologic tests and structural imaging for the etiologic diagnosis of dementia in italian expert centers. Alzheimer Dis Assoc Disord 2008 22 : 309 320.
31. Manly JJ, Tang MX, Schupf N et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008 63 : 494 506.
32. Chao LL, Pa J, Duarte A et al. Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord 2009 23 : 245 252.
33. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision): DSM-IV-TR, 4th Ed. Washington, DC : American Psychiatric Association, 2000.
34. Smith EE, Greenberg SM. Beta-amyloid, blood vessels, and brain function. Stroke 2009 40 : 2601 2606.
35. Scheltens P, Fox N, Barkhof F et al. Structural magnetic resonance imaging in the practical assessment of dementia: Beyond exclusion. Lancet Neurol 2002 1 : 13 21.
36. O'Brien JT. Role of imaging techniques in the diagnosis of dementia. Br J Radiol 2007 80 : S71 S77.
37. de Leon MJ, DeSanti S, Zinkowski R et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med 2004 256 : 205 223.
38. Smith A, King E, Hindley N et al. The experience of research participation and the value of diagnosis in dementia: Implications for practice. J Mental Health 1998 7 : 7.